Finance

The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.

Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.

The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.

The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.

A Silicon Valley Bank report reveals that healthcare sectors experienced strong growth in AI deal activity, especially in healthtech and biopharma.

While most provider and payer organizations are using some form of AI, very few are getting demonstrable value at scale across the enterprise, says Tom Lawry, managing director of Second Century Tech.

The company will use the funds to develop its employee assistance program platform, expand global clinical access and increase partnerships.

When it comes to making strategic AI investment deals, companies need to articulate their competitive advantage and how they view the market around them, says Jason Smith, venture acceleration fellow at MATTER.

The company will use the funds to augment key content partnerships.

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.